2021-08-27T15:30:33-05:00 2020-12-31 560574444 CHERRY BEKAERT LLP 1111 METROPOLITAN AVE STE 900 CHARLOTTE NC 28204 990 2020-01-01 010648145 ORTHOCAROLINA RESEARCH INSTITUTE INC ORTH 7043232260 2001 VAIL AVENUE NO 300 CHARLOTTE NC 28207 CHRISTI CADD EXECUTIVE DIRECTOR 7043232260 2021-08-14 1 CHRISTI CADD 999009999 AMANDA ADAMS P00748038 7043771678 3 AAL1 IAL1 2020 2022-09-23 18:48:47Z CHRISTI CADD 2001 VAIL AVENUE NO 300 CHARLOTTE NC 28207 2006703 0 X WWW.ORTHOCAROLINARESEARCH.ORG X 2002 NC ORTHOCAROLINA RESEARCH INSTITUTE (THE "INSTITUTE OR "OCRI") IS A NON-PROFIT ORGANIZATION DEDICATED TO PROMOTE, DEVELOP AND CONDUCT STATE-OF-THE-ART SCIENTIFIC RESEARCH AND EDUCATIONAL PROGRAMS FOR THE ADVANCEMENT OF ORTHOPAEDIC CARE. OCRI WORKS BOTH INDEPENDENTLY AS WELL AS IN COLLABORATION WITH UNIVERSITIES, HOSPITALS, PHARMACEUTICAL COMPANIES, HEALTHCARE DEVICE MANUFACTURERS AND OTHER ACADEMIC AND RESEARCH ORGANIZATIONS TO FURTHER PROMOTE THE MISSION. 16 16 0 0 0 0 1804808 1258438 1383549 748260 14 5 0 0 3188371 2006703 0 5000 0 0 0 0 0 0 8097 3077243 2128587 3077243 2133587 111128 -126884 3694363 3763254 400055 348634 3294308 3414620 X THE INSTITUTE'S MISSION AND PRIORITIES ARE CENTRALLY FOCUSED ON: (1) IMPROVED PATIENT CARE, (2) HIGH QUALITY RESEARCH TO DEVELOP NEW AND INNOVATIVE ORTHOPAEDIC DEVICES AND TECHNOLOGIES, AND (3) COLLABORATIVE AND MULTIDISCIPLINE FORUMS TO FURTHER ENHANCE STATE-OF-THE-ART MEDICAL HEALTHCARE. THE INSTITUTE IS CURRENTLY PARTICIPATING IN 45 ON-GOING FDA REGULATED CLINICAL TRIALS AND APPROXIMATELY 268 SCIENTIFIC OUTCOMES STUDIES AT THE TIME OF FILING. 0 0 1642416 748260 THE INSTITUTE'S MISSION AND PRIORITIES ARE CENTRALLY FOCUSED ON (1) IMPROVED ORTHOPEDIC PATIENT CARE (2) HIGH QUALITY EVIDENCE-BASED RESEARCH TO DEVELOP NEW AND INNOVATIVE ORTHOPEDIC DEVICES AND TECHNOLOGIES WHOSE GOAL IS TO ANSWER CLINICAL QUESTIONS FOR IMPROVED OUTCOMES. THE INSTITUTE IS CURRENTLY LEADING 45 ONGOING FDA-REGULATED CLINICAL TRIALS AND APPROXIMATELY 268 INVESTIGATOR-INITIATED SCIENTIFIC ACADEMIC STUDIES. RESEARCH IS DISSEMINATED THROUGH PEER REVIEWED JOURNAL PUBLICATIONS WITH GREATER THAN 96 PUBLICATIONS ANNUALLY. 29143 5000 OPERATION WALK CAROLINAS PROVIDES HIP AND KNEE JOINT REPLACEMENT SURGERIES AT NO COST TO PATIENTS IN UNDERSERVED COUNTRIES WHO HAVE NO ACCESS TO THIS LEVEL OF CARE. IN ADDITION, THE MEDICAL TEAM SPENDS TIME TEACHING THE ORTHOPEDIC SURGEONS, NURSES, PHYSICAL THERAPISTS AND OTHER HEALTHCARE PROFESSIONALS IN THAT COUNTRY ON THE MOST ADVANCED TECHNIQUES AND TREATMENTS FOR DISEASES OF THE HIP AND KNEE JOINTS IN ORDER TO BETTER SERVE THEIR PATIENTS. HEALTHCARE PROFESSIONALS FROM CHARLOTTE AREA NON-PROFIT HOSPITAL SYSTEMS COLLABORATE WITH THE ORTHOCAROLINA PHYSICIAN TEAM TO COMPLETE APPROXIMATELY 45 SURGERIES ON THOSE MOST SEVERE CASES OVER A PERIOD OF 5 TO 7 DAYS ANNUALLY. 129 THE INSTITUTE'S MISSION IS FOCUSED ON ADVANCING BOTH RESEARCH AND EDUCATION IN ORTHOPEDICS. THE ORTHOCAROLINA RESEARCH INSTITUTE HOSTS AN EDUCATIONAL CME (CONTINUING MEDICAL EDUCATION) SYMPOSIUM FOR 350-400 ORTHOPEDIC PROVIDERS AND ALLIED HEALTH CARE PROFESSIONALS EACH YEAR KNOWN AS OSCAR MILLER DAY. THIS SYMPOSIUM IS OVER 35 YEARS OLD, IS MARKETED TO THE SOUTH EASTERN U.S. AND ROTATES TOPICS ANNUALLY.THE 2020 OSCAR MILLER DAY WAS CANCELLED DUE TO COVID; EXPLORER'S PROGRAM WENT VIRTUAL ALONG WITH VIRTURAL EMPLOYMENT (THIS AFFECTED NORMAL BUSINESS EXPENSES); ALL RESEARCH PROGRAMS CONTINUED IN A VIRTUAL ENVIRONMENT. 1671688 1 1 0 0 0 0 0 0 0 0 1 1 0 0 0 1 1 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 18 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 16 16 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 NC SC X CHRISTI CADD 7043232260 2001 VAIL AVENUE STE 300 CHARLOTTE NC 28207 WILLIAM GRIFFIN MD CHAIRMAN 1.50 X X 0 0 0 WALTER B BEAVER MD DIRECTOR 0.10 X 0 0 0 BRANDON BOYD DIRECTOR 0.10 X 0 0 0 PATRICK M CONNOR MD DIRECTOR 0.10 X 0 0 0 BRUCE DARDEN MD DIRECTOR 0.50 X 0 0 0 CHARLES EAST III DIRECTOR 0.50 X 0 0 0 KENT ELLINGTON MD DIRECTOR 0.10 X 0 0 0 JOHN L FRALEY JR DIRECTOR 0.10 X 0 0 0 HARVEY GANTT DIRECTOR 0.10 X 0 0 0 GLENN GASTON MD DIRECTOR 0.50 X 0 0 0 JOE HSU MD DIRECTOR 0.10 X 0 0 0 MORRY JOHNSTON DIRECTOR 0.10 X 0 0 0 FRED R JONES DIRECTOR 1.00 X 0 0 0 THOMAS SMITH DIRECTOR 0.50 X 0 0 0 RICHARD E THIGPEN DIRECTOR 0.10 X 0 0 0 VELVA WOOLLEN DIRECTOR 0.10 X 0 0 0 CHRISTI CADD EXECUTIVE DIRECTOR 45.00 X 130425 0 32162 130425 0 32162 1 0 1 1 0 233569 1024869 1258438 RESEARCH 900099 748260 748260 748260 5 5 2006703 748260 0 5 5000 5000 18100 18100 16652 16652 259 259 8927 830 8097 10488 4665 5823 58286 58286 41576 6353 35223 3536 2155 1381 20174 20174 SHARED SERVICES 1602037 1320694 281343 STUDY EXPENSES 318201 318201 RESEARCH EQUIPMENT 9094 9094 MEDICAL SUPPLIES 8376 8376 12881 6244 6637 2133587 1671688 453802 8097 221506 558542 177300 198966 449139 206193 26558 28164 63378 63378 0 0 2803860 2755389 16000 16000 3694363 3763254 393755 347309 6300 1325 400055 348634 X 2510906 2850957 783402 563663 3294308 3414620 3694363 3763254 -126884 247196 0 X 0 1 X 1 0 X 945878 1128769 1118534 1804808 1258438 6256427 1067909 878272 863132 1383549 748260 4941122 2013787 2007041 1981666 3188357 2006698 11197549 753833 814292 691190 624256 509022 3392593 50276 367627 8524 352082 778509 804109 1181919 699714 624256 861104 4171102 7026447 129268 341184 10 14 5 470481 129268 341184 10 14 5 470481 2143055 2348225 1981676 3188371 2006703 11668030 0.60220 0.62640 0.04030 0.04970 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 16000 13878 13878 0 49500 49500 0 0 POOLED INV FUND - FFTC 2755389 F 2755389 X 2242546 247196 5299 252495 1990051 16652 16652 2006703 2122234 5299 5299 2116935 16652 16652 2133587 PART X, LINE 2: THE INSTITUTE ADOPTED FASB GUIDANCE ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. THE GUIDANCE CLARIFIES THE ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES RECOGNIZED IN AN ENTITY'S FINANCIAL STATEMENTS BY PRESCRIBING A RECOGNITION THRESHOLD AND MEASUREMENT ATTRIBUTE FOR THE FINANCIAL STATEMENT RECOGNITION AND MEASUREMENT OF A TAX POSITION TAKEN OR EXPECTED TO BE TAKEN. THE INSTITUTE'S POLICY IS TO RECORD A LIABILITY FOR ANY TAX POSITION TAKEN THAT IS BENEFICIAL TO THE INSTITUTE, INCLUDING ANY RELATED INTEREST AND PENALTIES, WHEN IT IS MORE LIKELY THAN NOT THE POSITION TAKEN BY MANAGEMENT WITH RESPECT TO A TRANSACTION OR CLASS OF TRANSACTIONS WILL BE OVERTURNED BY A TAXING AUTHORITY UPON EXAMINATION. MANAGEMENT BELIEVES THERE ARE NO SUCH POSITIONS AS OF DECEMBER 31, 2020 AND 2019 AND, ACCORDINGLY, NO LIABILITY HAS BEEN ACCRUED. CENTRAL AMERICA AND THE CARIBBEAN 0 0 PROGRAM SERVICES THIS PROGRAM PROVIDES FREE SURGICAL TREATMENT TO PATIENTS AND EDUCATION FOR IN-COUNTRY ORTHOPEDIC SURGEONS, NURSES, PHYSICAL THERAPISTS AND OTHER HEALTHCARE PROFESSIONALS ON THE MOST ADVANCED TREATMENTS AND SURGICAL TECHNIQUES FOR DISEASES OF THE HIP AND KNEE JOINTS. 29143 0 0 0 0 0 0 29143 0 29143 0 0 0 0 0 0 PART I, LINE 3: THE ACCRUAL METHOD OF ACCOUNTING WAS USED TO ACCOUNT FOR EXPENDITURES REPORTED IN PART I. PART III ACCOUNTING METHOD: 0 0 0 0 0 0 0 0 0 CHRISTI CADD EXECUTIVE DIRECTOR 118525 0 11900 0 0 0 9245 0 22917 0 162587 0 0 0 PART VII, SECTION A, LINE 5 THE INSTITUTE HAS AN AGREEMENT WITH AN UNRELATED ORGANIZATION TO SHARE EMPLOYEES. ALL PERSONS PROVIDING SERVICES TO THE INSTITUTE ARE EMPLOYEES OF THE UNRELATED ORGANIZATION. THE INSTITUTE REIMBURSES THE ORGANIZATION FOR THE SERVICES PROVIDED BY SUCH EMPLOYEES TO THE INSTITUTE. THIS AMOUNT HAS BEEN SHOWN IN PART IX AS "SHARED SERVICES EXPENSE." THE AMOUNTS SHOWN IN PART VII AND SCHEDULE J FOR CHRISTI CADD REFLECT THE AMOUNTS REIMBURSED BY THE INSTITUTE FOR HER SERVICES. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS FIRST REVIEWED AND APPROVED BY THE FINANCE COMMITTEE. FOLLOWING FINANCE COMMITTEE APPROVAL THE FORM 990 EMAILED TO ALL BOARD MEMBERS FOR THEIR REVIEW PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C DIRECTORS, OFFICERS AND KEY EMPLOYEES CERTIFY THAT THEY HAVE READ THE ORGANIZATION'S CONFLICT OF INTEREST POLICY AND HAVE DISCLOSED ANY RELATIONSHIPS WITH ANY OF THE ORGANIZATION'S CONTRACTING PARTIES ON THE ORGANIZATION'S CONFLICT OF INTEREST FORM. THE EXECUTIVE DIRECTOR REVIEWS THESE CERTIFIED FORMS, INCLUDING COMPARISONS TO THE PRIOR YEAR'S DISCLOSURES, AND CONFIRMS ANY CHANGES WITH THE SIGNERS. NO QUESTIONABLE RELATIONSHIP HAS BEEN NOTED OR BROUGHT TO THE ATTENTION OF THE APPROPRIATE GOVERNANCE GROUP. AT THE FEBRUARY MEETING OF THE FINANCE/AUDIT COMMITTEE, THE EXECUTIVE DIRECTOR REVIEWS WITH THE COMMITTEE THE COMPLIANCE STEPS TAKEN AND THE RESULTS FOR THE YEAR, AND CONFIRMS THAT NOTHING HAS BEEN BROUGHT TO HER ATTENTION DURING THE YEAR WHICH WOULD REQUIRE FURTHER EXAMINATION OF THE CURRENT CONFLICT OF INTEREST CERTIFICATIONS. THIS REVIEW IS INCLUDED AS PART OF THE COMMITTEE'S NORMAL REPORT TO THE BOARD REGARDING THE COMMITTEE'S ACTIVITIES. FORM 990, PART VI, SECTION B, LINE 15 THE EXECUTIVE COMMITTEE COMPLETES A PERFORMANCE EVALUATION AND ASSESSMENT OF SALARY FOR THE EXECUTIVE DIRECTOR ANNUALLY. THE EXECUTIVE COMMITTEE CONSISTS OF THE CHAIRMAN OF THE BOARD, CHAIRMAN OF THE RESEARCH ADVISORY COMMITTEE AND THE EXECUTIVE DIRECTOR. THE EXECUTIVE DIRECTOR IS A MEMBER OF THE EXECUTIVE COMMITTEE; HOWEVER, SHE HAS NO VOTE WHEN IT COMES TO PERSONAL PERFORMANCE AND SALARY. THE ORTHOCAROLINA RESEARCH INSTITUTE SHARES HUMAN RESOURCE SERVICES WITH ORTHOCAROLINA, PA. THE ORTHOCAROLINA, PA HUMAN RESOURCE DEPARTMENT PERFORMS PERIODIC REVIEWS OF ALL POSITIONS TO ENSURE SALARIES ARE COMPETITIVE AND FAIR WITHIN THE MARKET. IT IS COMMON PRACTICE FOR SALARIES TO INCREASE 3-5% DEPENDING ON INDIVIDUAL PERFORMANCE ANNUALLY. THE EXECUTIVE DIRECTOR BUDGETS SALARY INCREASES ANNUALLY AND SHOULD A STAFF SALARY INCREASE GREATER THAN THE 3-5% EXPECTED RANGE, IT IS PRESENTED BEFORE THE EXECUTIVE COMMITTEE FOR APPROVAL. ALL SALARY ADJUSTMENTS MADE BY THE ORTHOCAROLINA RESEARCH INSTITUTE ARE DOCUMENTED AND SUBMITTED TO THE ORTHOCAROLINA PA, HUMAN RESOURCE DEPARTMENT FOR FINAL APPROVAL BEFORE SUBMITTING TO PAYROLL. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, POLICIES AND PROCEDURES, AND FINANCIAL STATEMENTS ARE HELD IN THE OFFICE OF THE EXECUTIVE DIRECTOR. SUCH DOCUMENTS ARE AVAILABLE FOR REVIEW UPON REQUEST.